CollPlant Biotechnologies (CLGN) Change in Accured Expenses (2018 - 2025)
CollPlant Biotechnologies (CLGN) posted Change in Accured Expenses of $22000.0 for Q4 2025, up 120.37% on a QoQ basis from -$108000.0 in Q3 2025, and down 31.25% year-over-year from $32000.0 in Q4 2024.
CollPlant Biotechnologies (CLGN) Change in Accured Expenses (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies' Change in Accured Expenses history runs 8 years deep, the most recent figure standing at $22000.0 for Q4 2025.
- Quarterly Change in Accured Expenses fell 31.25% year-over-year to $22000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $82000.0 (up 123.23% YoY) and the FY2025 annual result came in at -$46000.0, up 86.97% from the prior year.
- Change in Accured Expenses was $22000.0 for Q4 2025 at CollPlant Biotechnologies, up from -$108000.0 in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $476000.0 in Q4 2022 and bottomed at -$627000.0 in Q3 2021.
- A 5-year average of -$78157.9 and a median of -$80000.0 in 2021 frame the typical range for Change in Accured Expenses.
- Annual changes were most pronounced in 2021 — Change in Accured Expenses sank 433.33% — and 2022, when it surged 202.59%.
- CollPlant Biotechnologies' Change in Accured Expenses stood at -$464000.0 in 2021, then jumped by 202.59% to $476000.0 in 2022, then slumped by 31.09% to $328000.0 in 2023, then plunged by 90.24% to $32000.0 in 2024, then slumped by 31.25% to $22000.0 in 2025.
- Business Quant data shows CLGN's Change in Accured Expenses at $22000.0 in Q4 2025, -$108000.0 in Q3 2025, and $136000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1.13 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 931,000.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -16.82 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 23.10 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 107.70 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -16.74 Mn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | -108,000.00 |
| Sep 30, 2025 | -108,000.00 |
| Jun 30, 2025 | 136,000.00 |
| Jun 30, 2025 | 136,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Dec 31, 2024 | 32,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Sep 30, 2024 | -52,000.00 |
| Jun 30, 2024 | -394,000.00 |
| Jun 30, 2024 | -394,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Mar 31, 2024 | 61,000.00 |
| Dec 31, 2023 | 328,000.00 |
| Dec 31, 2023 | 328,000.00 |
| Sep 30, 2023 | -102,000.00 |
| Sep 30, 2023 | -102,000.00 |
| Jun 30, 2023 | -88,000.00 |
| Jun 30, 2023 | -88,000.00 |